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1 |  INTRODUCTION
We present a case of a 66-year-old woman with metastatic 
vulvar squamous cell carcinoma that developed within an 
area of chronic hidradenitis suppurativa in the groin and re-
view the literature. The progression of SCC was so severe 
that she passed away only a month into her hospital stay.
Hidradenitis suppurativa (HS) is a chronic inflammatory 
skin disorder, characterized by recurrent deep-seated, inflam-
matory nodules in apocrine gland–bearing areas of the body, 
that is, the axillae, groin, and perineum. The nodules may 
progressively expand to abscesses and draining sinus tracts 
with subsequent scarring. Chronic, long-standing inflamma-
tion in HS may lead to the development of squamous cell 
carcinoma (SCC), a rare albeit the most serious complication 
of HS.
We present a case herein of a woman who developed SCC 
of the vulva in the setting of chronic, long-standing HS with 
fatal outcome and update the literature on this topic to date.
A search in the PubMed database was conducted until 
the 25th of September 2019 to identify articles describing 
patients with HS who developed SCC. All of the articles 
reviewed were published in English. The search terminol-
ogy included the following: “Hidradenitis suppurativa AND 
squamous cell carcinoma.”
2 |  CASE REPORT
The patient was a 66-year-old Caucasian female with a his-
tory of HS since 2010 with Hurley stage III lesions in the 
groins with six nodules and six sinus tracts. She had a HSS 
score of 63, DLQI score of 13, and visual analogue scale 
(VAS) for overall disease-related distress of 5.5 and VAS 
for boil-associated pain from boils in the past month was 
0. The patient also had hypertension, smoked 20 cigarettes 
per day for 54 years and had a BMI of 26.4 kg/m2. She had 
no family history of HS. The patient was first seen in our 
clinic in 2016, where treatment with topical clindamycin 
twice daily and oral tetracycline 500 mg twice daily was 
initiated along with topical corticosteroids for local ec-
zema. At 3-month follow-up, the skin was characterized by 
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Abstract
Squamous cell carcinoma arising in hidradenitis suppurativa (HS) is a rare albeit the 
most serious complication in HS, with a reported fatality of up to 42.9%. This calls 
for greater clinical awareness in patients with long-standing chronic HS.
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fibrotic and thickened cicatricial areas with purulent drain-
age and inflamed nodules. Topical metronidazole and oral 
lymecycline 300 mg twice daily were administered and the 
patient was referred to wide excisional plastic surgery of 
the groins, provided she stopped smoking 2 months prior 
to surgery.
Surgery was canceled due to continued smoking, and no 
further surgery was planned. She failed to seek further help for 
her HS until she was admitted 3 years later after severe worsen-
ing of HS, with multiple severe fistulae and a large foul-smell-
ing tumor with drainage in the left groin and necrosis of lymph 
nodes (Figure 1). A PET-CT showed ingrowth and destruction 
of the left ramus inferior of the pelvis and gland metastasis 
under the diaphragm. Biopsy demonstrated invasive poorly 
differentiated SCC, transformed from several years of chronic 
HS. The clinical picture was compatible with ulcerating vulvar 
cancer, and the patient received radiation therapy as a palliative 
measure. However, she was shortly thereafter deemed terminal 
and died 1 month after the initial metastatic SCC diagnosis.
F I G U R E  1  Squamous cell carcinoma arising in hidradenitis 
suppurativa in left groin. Presented with multiple severe fistulae in skin 
and subcutis, a large ulcerating cancer with drainage and necrosis of 
lymph nodes T
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2.1 | Prevalence of squamous cell carcinoma 
in patients with hidradenitis suppurativa
A paper in 2016 by Jourabchi et al1 and in 2018 by Chapman 
et al2 described 80 and five cases, respectively, on SCC in pa-
tients with HS cases in the English literature. We found five 
additional cases of SCC arising from HS reported in the liter-
ature since the last updated review by Chapman et al2 (Table 
1). Among these five new cases, the mean history of HS prior 
to SCC diagnosis was 16 years, and the mean age at diagnosis 
was 51.2  years. SCC developed predominantly from long-
standing HS of the gluteal and perianal areas. A history of to-
bacco use was reported in two of the five cases. Interestingly, 
the occurrence of SCC in the context of axillary HS was not 
reported in the English literature before Dessinioti.3
3 |  DISCUSSION
Our case highlights a rare consequence of HS, where long-
standing and poorly controlled inflammation transforms into 
SCC. The development of SCC in the setting of HS is thought 
to be rare, with an estimated prevalence of SCC among pa-
tients with HS of up to 4.6%, concluded in a cohort study of 
217 patients with HS by Lavogiez et al4 The prognosis is poor 
due to the advanced stage of SCC at the time of diagnosis and 
difficulty in obtaining a representative biopsy in early stages 
of cancer development. A review of published cases of SCC 
arising in chronic HS determined that nine of the 21 patients 
(42.9%) died of their disease.5 Including our patient, three 
of three of the six patients (50%) in this review passed away 
after their metastatic SCC diagnosis, supporting the severity 
of this compilation. However, fatality could be speculated to 
be overemphasized due to publication bias.
The diagnosis of malignancy in patients with HS is less 
straight forward, since chronic draining wounds can mimic 
malignant ulceration. Biopsies are not required to diagnose 
HS, but should be considered in the setting of an uncertain 
clinical picture to rule out malignant transformation.
The Danish Board of Health recommends a 6-week smok-
ing cessation prior to surgical removal of HS. However, our 
patient continued smoking and was withheld surgical exci-
sion while her HS severely worsened, to a point where sur-
gery was not possible anymore. It is an ethical dilemma, 
whether surgery should be postponed until smoking cessation 
in every case. In a former study by Losanoff,6 surgery is the 
only known treatment method that provides a real chance for 
a cure for both HS and a complicating carcinoma. Patients 
that do not initially undergo surgery for severe HS can po-
tentially develop cancerous degeneration as in the present 
case report. This is why complete excision in severe cases of 
HS is also indicated to avoid chronic progression of the dis-
ease. Retrospectively, less strict smoking policy could have 
allowed surgery and perhaps avoided cancer transformation 
and death. It is important to consider the socioeconomic situ-
ation of the patient in the treatment as well. Our patient only 
had one distant relative for support, lived alone and could not 
take care of herself, so she failed to seek medical attention 
even though her disease severely worsened. Support for the 
patients with low socioeconomic status including smoking 
cessation and weight loss should be considered for optimal 
wound healing7 and adherence to therapy.
Biologic drugs are used for moderate to severe HS or in 
nonoperable patients, and have shown promising results.8 
However, they are speculated to be associated with increased 
risk of nonmelanoma skin cancer due to their immunosuppres-
sive properties. Further, it is well known that chronic skin in-
flammation is linked to higher risk of malignant transformation 
as our case supports. Further research focusing on the risk of 
developing SCC in HS patients is needed to elucidate whether 
long-term treatment with biologics may lead to prevention or 
promotion of malignant transformation of chronic skin inflam-
mation. Our patient did not receive biologic therapy.
4 |  CONCLUSION
In conclusion, patients suffering from chronic inflammatory 
processes should be closely monitored with a high index of 
suspicion of malignancy, since SCC in long-standing HS is 
a rare, but potentially fatal complication. HS in the perianal, 
perineal, and sacral region should be treated early with wide 
and radical surgical excision due to the risk of malignant de-
generation and development of aggressive SCC particularly 
in these regions. Dispensation from smoking policy should 
be considered in selected patients.
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